164 related articles for article (PubMed ID: 38675489)
1. Comparison of Glioblastoma Cell Culture Platforms Based on Transcriptional Similarity with Paired Tissue.
Park J; Koh I; Cha J; Oh Y; Shim JK; Kim H; Moon JH; Kim EH; Chang JH; Kim P; Kang SG
Pharmaceuticals (Basel); 2024 Apr; 17(4):. PubMed ID: 38675489
[TBL] [Abstract][Full Text] [Related]
2. Decellularized brain extracellular matrix slice glioblastoma culture model recapitulates the interaction between cells and the extracellular matrix without a nutrient-oxygen gradient interference.
Wang C; Zhao Q; Zheng X; Li S; Chen J; Zhao H; Chen F; Cui L; Li W
Acta Biomater; 2023 Mar; 158():132-150. PubMed ID: 36565784
[TBL] [Abstract][Full Text] [Related]
3. Classification of IDH wild-type glioblastoma tumorspheres into low- and high-invasion groups based on their transcriptional program.
Park J; Shim JK; Lee M; Kim D; Yoon SJ; Moon JH; Kim EH; Park JY; Chang JH; Kang SG
Br J Cancer; 2023 Oct; 129(7):1061-1070. PubMed ID: 37558923
[TBL] [Abstract][Full Text] [Related]
4. Mesenchymal Stem-Like Cells Derived from the Ventricle More Effectively Enhance Invasiveness of Glioblastoma Than Those Derived from the Tumor.
Park J; Lee D; Shim JK; Yoon SJ; Moon JH; Kim EH; Chang JH; Lee SJ; Kang SG
Yonsei Med J; 2023 Mar; 64(3):157-166. PubMed ID: 36825341
[TBL] [Abstract][Full Text] [Related]
5. Combined effects of niclosamide and temozolomide against human glioblastoma tumorspheres.
Oh HC; Shim JK; Park J; Lee JH; Choi RJ; Kim NH; Kim HS; Moon JH; Kim EH; Chang JH; Yook JI; Kang SG
J Cancer Res Clin Oncol; 2020 Nov; 146(11):2817-2828. PubMed ID: 32712753
[TBL] [Abstract][Full Text] [Related]
6. Co-expression of cancer driver genes: IDH-wildtype glioblastoma-derived tumorspheres.
Yoon SJ; Son HY; Shim JK; Moon JH; Kim EH; Chang JH; Teo WY; Kim SH; Park SW; Huh YM; Kang SG
J Transl Med; 2020 Dec; 18(1):482. PubMed ID: 33317554
[TBL] [Abstract][Full Text] [Related]
7. Inhibiting stemness and invasive properties of glioblastoma tumorsphere by combined treatment with temozolomide and a newly designed biguanide (HL156A).
Choi J; Lee JH; Koh I; Shim JK; Park J; Jeon JY; Yun M; Kim SH; Yook JI; Kim EH; Chang JH; Kim SH; Huh YM; Lee SJ; Pollak M; Kim P; Kang SG; Cheong JH
Oncotarget; 2016 Oct; 7(40):65643-65659. PubMed ID: 27582539
[TBL] [Abstract][Full Text] [Related]
8. Combined treatment with 2'-hydroxycinnamaldehyde and temozolomide suppresses glioblastoma tumorspheres by decreasing stemness and invasiveness.
Jeong H; Park J; Shim JK; Lee JE; Kim NH; Kim HS; Chang JH; Yook JI; Kang SG
J Neurooncol; 2019 May; 143(1):69-77. PubMed ID: 30887242
[TBL] [Abstract][Full Text] [Related]
9. C5α secreted by tumor mesenchymal stem-like cells mediates resistance to 5-aminolevulinic acid-based photodynamic therapy against glioblastoma tumorspheres.
Park J; Oh SJ; Shim JK; Ji YB; Moon JH; Kim EH; Huh YM; Suh JS; Chang JH; Lee SJ; Kang SG
J Cancer Res Clin Oncol; 2023 Jul; 149(8):4391-4402. PubMed ID: 36107247
[TBL] [Abstract][Full Text] [Related]
10. The mode and dynamics of glioblastoma cell invasion into a decellularized tissue-derived extracellular matrix-based three-dimensional tumor model.
Koh I; Cha J; Park J; Choi J; Kang SG; Kim P
Sci Rep; 2018 Mar; 8(1):4608. PubMed ID: 29545552
[TBL] [Abstract][Full Text] [Related]
11. Etomoxir, a carnitine palmitoyltransferase 1 inhibitor, combined with temozolomide reduces stemness and invasiveness in patient-derived glioblastoma tumorspheres.
Shim JK; Choi S; Yoon SJ; Choi RJ; Park J; Lee EH; Cho HJ; Lee S; Teo WY; Moon JH; Kim HS; Kim EH; Cheong JH; Chang JH; Yook JI; Kang SG
Cancer Cell Int; 2022 Oct; 22(1):309. PubMed ID: 36221088
[TBL] [Abstract][Full Text] [Related]
12. Bioengineered 3D brain tumor model to elucidate the effects of matrix stiffness on glioblastoma cell behavior using PEG-based hydrogels.
Wang C; Tong X; Yang F
Mol Pharm; 2014 Jul; 11(7):2115-25. PubMed ID: 24712441
[TBL] [Abstract][Full Text] [Related]
13. A lignan from Alnus japonica inhibits glioblastoma tumorspheres by suppression of FOXM1.
Shim JK; Lim SH; Jeong JH; Choi RJ; Oh Y; Park J; Choi S; Hong J; Kim SJ; Moon JH; Kim EH; Teo WY; Park BJ; Chang JH; Ryu JH; Kang SG
Sci Rep; 2022 Aug; 12(1):13990. PubMed ID: 35978012
[TBL] [Abstract][Full Text] [Related]
14. A novel biguanide (IM1761065) inhibits bioenergetics of glioblastoma tumorspheres.
Roh TH; Lee JH; Kim SJ; Shim JK; Park J; Yoon SJ; Teo WY; Kim SH; Chang JH; Kang SG
J Neurooncol; 2022 Jan; 156(1):139-151. PubMed ID: 34811601
[TBL] [Abstract][Full Text] [Related]
15. Brain-Mimetic 3D Culture Platforms Allow Investigation of Cooperative Effects of Extracellular Matrix Features on Therapeutic Resistance in Glioblastoma.
Xiao W; Zhang R; Sohrabi A; Ehsanipour A; Sun S; Liang J; Walthers CM; Ta L; Nathanson DA; Seidlits SK
Cancer Res; 2018 Mar; 78(5):1358-1370. PubMed ID: 29282221
[TBL] [Abstract][Full Text] [Related]
16. Hyaluronic-Acid Based Hydrogels for 3-Dimensional Culture of Patient-Derived Glioblastoma Cells.
Xiao W; Ehsanipour A; Sohrabi A; Seidlits SK
J Vis Exp; 2018 Aug; (138):. PubMed ID: 30199037
[TBL] [Abstract][Full Text] [Related]
17. A tumorsphere model of glioblastoma multiforme with intratumoral heterogeneity for quantitative analysis of cellular migration and drug response.
Gudbergsson JM; Kostrikov S; Johnsen KB; Fliedner FP; Stolberg CB; Humle N; Hansen AE; Kristensen BW; Christiansen G; Kjær A; Andresen TL; Duroux M
Exp Cell Res; 2019 Jun; 379(1):73-82. PubMed ID: 30922921
[TBL] [Abstract][Full Text] [Related]
18. Bioengineered scaffolds for 3D culture demonstrate extracellular matrix-mediated mechanisms of chemotherapy resistance in glioblastoma.
Xiao W; Wang S; Zhang R; Sohrabi A; Yu Q; Liu S; Ehsanipour A; Liang J; Bierman RD; Nathanson DA; Seidlits SK
Matrix Biol; 2020 Jan; 85-86():128-146. PubMed ID: 31028838
[TBL] [Abstract][Full Text] [Related]
19. Biomanufacturing of glioblastoma organoids exhibiting hierarchical and spatially organized tumor microenvironment via transdifferentiation.
Park S; Avera AD; Kim Y
Biotechnol Bioeng; 2022 Nov; 119(11):3252-3274. PubMed ID: 35869574
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of glioblastoma tumorspheres by combined treatment with 2-deoxyglucose and metformin.
Kim EH; Lee JH; Oh Y; Koh I; Shim JK; Park J; Choi J; Yun M; Jeon JY; Huh YM; Chang JH; Kim SH; Kim KS; Cheong JH; Kim P; Kang SG
Neuro Oncol; 2017 Feb; 19(2):197-207. PubMed ID: 27571886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
